DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr | ₹-139 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
| Mar2021 | ₹-139 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | Positive | |
| Mar2021 | ₹-139 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹25,903.4 Cr | -1.1% | -1.4% | 10.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹120,126.0 Cr | 3.2% | 6.6% | 20.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹97,913.2 Cr | 6% | -0.9% | -15.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹74,586.1 Cr | 6.3% | 4.3% | 34.2% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹39,693.2 Cr | 5.4% | 3.8% | 36.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,246.5 Cr | -0.7% | 3.1% | 12.8% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -1.1% |
-1.4% |
10.5% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses